je.st
news
Home
› Sprint Bioscience Enters into Collaboration with Bayer Healthcare on Tumor Metabolism Program
Sprint Bioscience Enters into Collaboration with Bayer Healthcare on Tumor Metabolism Program
2015-07-28 09:16:55| Appliances - Topix.net
Sprint Bioscience AB and Bayer HealthCare have entered into a collaboration and license agreement for the research, development, and commercialization of oncological drug candidates. Under the agreement, Sprint Bioscience licenses an early-stage inhibitor program targeting tumor metabolism to Bayer.
Tags: program
collaboration
healthcare
metabolism
Category:Consumer Goods and Services